US researchers found that cancer patients with COVID-19 who were being administered with hydroxychloroquine with the antibiotic azithromycin drug combination to counter the coronavirus were three times more likely to die within 30 days than those who got either drug alone.
from Zee News :World https://ift.tt/2XdHMjr
Home »
latest news
,
latest news headlines
,
latest news in English
,
latest news in Hindi
,
latest news in India
,
latest news today
,
latest news update
,
Zee News :World
» Hydroxychloroquine combination risky for cancer patients with COVID-19: Study
No comments:
Post a Comment